NCT05615649 - Expanded Indications in the Pediatric BONEBRIDGE Population | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 3, 2023

Primary Completion Date

January 31, 2026

Study Completion Date

July 31, 2026

Conditions

Hearing Loss, ConductiveHearing Loss, Mixed

Interventions

DEVICE

MED-EL BONEBRIDGE Bone Conduction Implant

Subjects will be implanted with the MED-EL BONEBRIDGE Bone Conduction Implant System. Subjects will be fit with the appropriate external audio sound processor.

Trial Locations (6)

27517

University of North Carolina, Chapel Hill

33136

University of Miami, Miami

43210

The Ohio State University/Nationwide Children's Hospital, Columbus

80045

University of Colorado Health/Children's Hospital of Colorado, Aurora

84132

University of Utah Health/Primary Children's Hospital, Salt Lake City

07103

University Hospital Newark/Rutgers New Jersey Medical School, Newark